Adjuvant chemotherapy use for medicare beneficiaries with stage II colon cancer Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Colonic Neoplasms

abstract

  • A substantial percentage of Medicare beneficiaries with resected stage II colon cancer receive adjuvant chemotherapy despite its uncertain benefit.

publication date

  • October 2002

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2002.11.084

PubMed ID

  • 12351597

Additional Document Info

start page

  • 3999

end page

  • 4005

volume

  • 20

number

  • 19